Blog Archives

Blog

Certara’s Virtual Twin® QSP Models: Transforming Rare Disease Research into Clinical Insights

Certara’s Virtual Twin® QSP Models are transforming rare disease drug development, with real-world insights from…

CertaraNovember 25, 2025

Blog

The Proposed Food and Drug Administration (FDA) Development Safety Update Report (DSUR) Guidance

Learn how FDA DSUR requirements reshape drug safety reporting, align with ICH E2F, and impact…

CertaraNovember 24, 2025

Blog

From Insight to Impact: Certainty EMEA 2025

See how GenAI, unified digital trials, and a Totality of Evidence approach transform regulatory docs,…

CertaraNovember 17, 2025

Blog

Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals

Quantitative Systems Pharmacology (QSP) modeling tackles preclinical radiopharmaceuticals development challenges, from design to dose optimization.

CertaraNovember 14, 2025

Blog

Using M&S to Evaluate Oncology Drug Dosing

Learn how modeling & simulation improves oncology drug dosing, optimizing safety, efficacy, and personalized treatment…

CertaraNovember 14, 2025

Blog

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…

CertaraNovember 13, 2025

Blog

Empowering the PK Community: Insights from the Phoenix® User Events

Explore insights from the Phoenix User Events in Europe, where experts shared innovations in automation,…

CertaraNovember 3, 2025

Blog

How To Design a Case Report Form | 7 Best Practice Steps

Discover how to design a case report form with our 7 best practices: improve data…

CertaraNovember 3, 2025

Blog

At Certara, we’re proud to support WBUR, Boston’s NPR.

Certara supports public radio because NPR is aligned with our values and helps us spread…

CertaraOctober 29, 2025

Blog

Key Lessons & Opportunities in applying NCA and PopPK to ADCs

Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide…

CertaraOctober 24, 2025

Blog

Certara’s Virtual Twin® QSP Models: Transforming Rare Disease Research into Clinical Insights

The Proposed Food and Drug Administration (FDA) Development Safety Update Report (DSUR) Guidance

From Insight to Impact: Certainty EMEA 2025

Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals

Using M&S to Evaluate Oncology Drug Dosing

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

Empowering the PK Community: Insights from the Phoenix® User Events

How To Design a Case Report Form | 7 Best Practice Steps

At Certara, we’re proud to support WBUR, Boston’s NPR.

Key Lessons & Opportunities in applying NCA and PopPK to ADCs

Newsletter sign up

Quick links

Solutions

Contact